Clinical Trials

Clinical Trial Detail

Return to search results.

Phase I Study of Fenretinide (4-HPR, NSC 374551) Lym-X-Sorb (LXS) Oral Powder in Patients with Recurrent or Resistant Neuroblastoma (IND # 68254)

Research Study Number       NANT 2004-04
    
Principal Investigator       Julie Park, MD
    
Phase       I

Look up trial at NIH



Research Study Number       NANT 2004-04
    
Contact       Seattle Children’s Outpatient Attending MD
    
Telephone       (206) 987-2106
    
Other URLs that may be
of interest include
      http://nant.org/
http://cancer.seattlechildrens.org/
   

Keywords
Neuroblastoma; Solid Tumors

Disclaimer: We update this information regularly. However, what you read today may not be completely up to date.

Please remember:

  • Talk to your health care providers first before making decisions about your health care.
  • Whether you are eligible for a research study depends on many things. There are specific requirements to be in research studies. These requirements are different for each study.

Subscribe to an RSS feed of all trials

Fred Hutchinson Cancer Research Center is a world leader in research to prevent, detect and treat cancer and other life-threatening diseases.